MedTech Smarts with Rita

Ep. 3 - Funding Innovation: Smart Capital Strategies in a Tight MedTech Market

43 min · 28. elo 2025
jakson Ep. 3 - Funding Innovation: Smart Capital Strategies in a Tight MedTech Market kansikuva

Kuvaus

This week on MedTech Smarts with Rita, the panel tackles today’s toughest funding challenges in MedTech, from shrinking venture capital to limited grants and the impact on commercialization timelines. Special guest Nikin Shah reveals how creative lending and strategic partnerships offer fresh pathways for growth, while experts Rita and Richard share actionable insights for leveraging regulatory planning as a business asset. The episode spotlights tools like LuminLogic, showing how robust compliance systems can boost investor confidence and accelerate execution. Whether you're a founder or investor, this discussion delivers strategies for navigating the capital crunch and building scalable, resilient MedTech companies.

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity MedTech Smarts with Rita-yhteisöön!

Aloita nyt

1 kuukausi hintaan 1 €

Sitten 7,99 € / kuukausi · Peru milloin tahansa.

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

6 jaksot

jakson Ep. 3 - Funding Innovation: Smart Capital Strategies in a Tight MedTech Market kansikuva

Ep. 3 - Funding Innovation: Smart Capital Strategies in a Tight MedTech Market

This week on MedTech Smarts with Rita, the panel tackles today’s toughest funding challenges in MedTech, from shrinking venture capital to limited grants and the impact on commercialization timelines. Special guest Nikin Shah reveals how creative lending and strategic partnerships offer fresh pathways for growth, while experts Rita and Richard share actionable insights for leveraging regulatory planning as a business asset. The episode spotlights tools like LuminLogic, showing how robust compliance systems can boost investor confidence and accelerate execution. Whether you're a founder or investor, this discussion delivers strategies for navigating the capital crunch and building scalable, resilient MedTech companies.

28. elo 202543 min